Franklin Resources »

Kyverna Therapeutics shares owned by Franklin Resources

Quarter-by-quarter ownership of Kyverna Therapeutics shares owned by Franklin Resources from 13F filings

Historical chart of Franklin Resources investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Franklin Resources consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Franklin Resources

Quarter filed Position value Share count Share price at filing
2024-03-31 $11M 461k 24.84

More positions owned by Franklin Resources

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Bank of America Corporation (BAC)
Visa Com Cl A (V)
Procter & Gamble Company (PG)

View all positions for Franklin Resources

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Northpond Ventures
Bain Capital Life Sciences Investors
Deerfield Management Company
Jennison Associates
T. Rowe Price Associates
Insight Holdings
Commodore Capital
Jpmorgan Chase & Co
BlackRock
Millennium Management
Henderson Group
Adage Capital Partners GP
Citadel Advisors
Logos Global Management

View all funds holding Kyverna Therapeutics